The biotech index looks sad so far. However, considering a specific stock, we have that we have bullish divergences, although not sure, the level, as well as the ema200 for the week.
From the fundamental one, you can attract interest in RNAi technology. Recently, DRNA was purchased with their platform, this company has its own, respectively, and the same areas of research.
From the fundamental one, you can attract interest in RNAi technology. Recently, DRNA was purchased with their platform, this company has its own, respectively, and the same areas of research.